Violation Tracker Individual Record

Company: 
Genentech Inc.
Current Parent Company: 
Roche
Penalty: 
$19,000,000
Year: 
2000
Date: 
January 27, 2000
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
False Claims Act and related
Violation Description: 

Genentech paid $19 million to state Medicaid programs as part of a $50 million civil and criminal settlement with the federal government of allegations that the company promoted Protropin, a human growth hormone, for uses that had not been approved by the Food and Drug Administration.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Switzerland
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.